Grimm, Donata http://orcid.org/0000-0002-4706-2335
Voiss, Petra
Paepke, Daniela
Dietmaier, Johanna
Cramer, Holger
Kümmel, Sherko
Beckmann, Matthias W.
Woelber, Linn
Schmalfeldt, Barbara
Freitag, Ulrich
Kalder, Matthias
Wallwiener, Markus
Theuser, Anna-Katharin
Hack, Carolin C.
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Article History
Received: 17 August 2020
Accepted: 31 October 2020
First Online: 17 November 2020
Compliance with ethical standards
:
: DG: research support: Greiner Bio-One GmbH; honoraria: Roche, ESOP, Genomic Health, Oncotype, PV: grant: Karl and Veronica Carstens Foundation; consulting role: Novartis; honoraria: Roche, Novartis, Celgene. CCH: honoraria from Roche and Novartis. SK: personal fees: Roche/Gentech, Genomic Health, Novartis, Amgen, Celgene, Daiichi Sankyo, Astra Zeneca, Somatex, MSD, Pfizer, PFM medical, Lilly, Sonoscape, nonfinancial support from Roche, Daiichi Sankyo, Sonoscape, outside the research submitted here. All other authors hereby declare that they had no conflicts of interest in preparing the present manuscript.
: Research involving human participants.
: Informed consent was obtained from all individual participants included in the study. The study protocol was designed in accordance with the Declaration of Helsinki, and ethical approval was obtained from the respective ethics committees (reference number Hamburg PV5847).
: All authors have provided written consent for publication.